Wave Life Sciences Ltd (WVE)
Healthcare
Biotechnology
5.70 $
+4.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Wave Life Sciences Ltd (WVE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.1% of the shares are freely tradable; institutional investors hold 82.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
82.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
15.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
48.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
10.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
197Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 13.69 | 26,975,505 | +48.2 | 03/31/2026 |
| GSK PLC | 9.26 | 18,245,691 | +0.0 | 03/31/2026 |
| BlackRock Inc | 7.16 | 14,117,412 | +11.6 | 03/31/2026 |
| Maverick Capital Ltd | 5.16 | 10,161,399 | +9.5 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 4.42 | 8,704,550 | +17.5 | 03/31/2026 |
| Driehaus Capital Management LLC | 2.76 | 5,431,021 | -17.5 | 03/31/2026 |
| Federated Hermes Inc | 2.70 | 5,317,457 | +12.1 | 03/31/2026 |
| FMR Inc | 2.64 | 5,192,761 | -65.7 | 03/31/2026 |
| 683 Capital Management LLC | 2.49 | 4,900,000 | +22.0 | 03/31/2026 |
| PRIMECAP Management Company | 2.45 | 4,832,952 | +18.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.